ResMed's Australia shares top losses on ASX200 as Q3 results miss estimates

ResMed

29/04/2022 02:38

** ASX-listed shares of U.S.-based ResMed Inc  RMD.AX  drop 
as much as 6.7% to A$28.36, their lowest since June 11, 2021
    ** The medical device maker posts Q3 adjusted earnings of
$1.32 per share, missing the mean expectation of eight analysts
of $1.42 per share  urn:newsml:reuters.com:*:nASX1k9XBN
    ** RMD reports Q3 revenue of $864.5, up 12.5% from a year
ago, but lower than analysts' avg. estimate of $897.04 mln  
    ** RMD top percentage loser on the benchmark ASX200 index
 .AXJO 
    ** Stock posts its biggest intraday pct. fall since March 24
    ** Stock down 15.1% this year, as of last close
    

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))